A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

Original Article

D. Blockmans, S.K. Penn, A.R. Setty, W.A. Schmidt, A. Rubbert-Roth, E.M. Hauge, H.I. Keen, T. Ishii, N. Khalidi, C. Dejaco, M.C. Cid, B. Hellmich, M. Liu, W. Zhao, I. Lagunes, A.B. Romero, P.K. Wung, and P.A. Merkel

N Engl J Med 2025;392:2013-2024

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
05/28/2025
Course expires: 
05/29/2027

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please sign in or create an account to take the course.